I’ve often found myself sitting across from couples in my clinic, watching their faces as they grapple with the uncertainties of IVF. It’s a moment of vulnerability, where their dreams hang in the balance, and my role as a doctor is to guide them through the fog of expectations. Similarly, I find myself in a comparable position as an angel investor. Founders, much like my patients, are brimming with hope, caught between the potential of their ideas and the harsh realities of the market.
Both these journeys—IVF and startups—are fraught with challenges that hinge on one crucial factor: managing expectations. I’ve been pondering this intersection recently, particularly as I’ve watched both patients and founders navigate the emotional rollercoaster that defines their paths. What strikes me is how similar these journeys are, and how the lessons from one can often illuminate the struggles of the other.
In the world of IVF, it’s easy to be seduced by the promise of technology. Success rates, advanced genetic testing, and the latest in reproductive science—all seem to suggest that a baby is just a procedure away. But the truth is, even with all the advancements, IVF is not a guarantee. The numbers tell us that the success rate of IVF cycles, on average, hovers around 30% per attempt. This is a hard pill to swallow, both for the hopeful parents and for us as practitioners who want nothing more than to deliver good news.
The challenge lies in setting realistic expectations from the outset. I’m candid with my patients. I tell them that while technology can tilt the odds, it cannot assure success. It’s a delicate balance of hope and realism—a dance of optimism tempered by the reality of biology. This is not unlike the startup world, where founders often believe that their passion and innovation will naturally translate into market success. Yet, the grim reality is that about 90% of startups fail. It’s a statistic that echoes the unpredictability of IVF outcomes.
In both fields, the journey begins with a dream. For my patients, it’s the dream of parenthood. For founders, it’s the vision of building something transformative. But dreams, as I often remind them, are just the starting point. The real work involves navigating setbacks, managing expectations, and making informed decisions based on the realities at hand. This is where the role of an advisor—be it a doctor or an investor—becomes pivotal.
In my experience, transparency is key. Whether I’m discussing potential outcomes with a patient or evaluating a startup pitch, honesty is non-negotiable. In my blog post, Why Transparent Conversations Are the Cornerstone of Both IVF and Investment Success, I delve deeper into how openness forms the bedrock of trust. Patients need to understand the limitations, just as founders need to grasp the market realities. It’s about preparing for the worst while hoping for the best—a mantra that applies equally to both fields.
Let me share a story that illustrates this point. A few years ago, I worked with a couple who had undergone multiple IVF cycles without success. Each failure was a blow, and their resilience was wearing thin. It was during one of our candid discussions that they decided to consider adoption. It was not the path they had initially envisioned, but it became a beautiful journey nonetheless. Similarly, I’ve seen founders pivot their business models, not out of defeat, but out of a newfound understanding of their market. These are the moments that underscore the importance of flexibility and adaptability.
One of the startups I invested in faced a similar crossroad. After a couple of years of struggling to find traction, they had to pivot their core offering. It wasn’t an easy decision, but it was necessary. The founders were initially resistant; their original idea was their “baby,” after all. But once they embraced the need for change, their fortunes turned. Their story is a testament to what I often tell both patients and entrepreneurs: sometimes, the path to success is not the one you first envisioned.
I’ve often said that the courage to begin again is a trait both my IVF patients and startup founders share. It’s a conviction I’ve explored in my post, IVF Teaches Me What Startups Need: The Courage to Begin Again. Whether it’s commencing another IVF cycle or reimagining a business model, resilience is the common thread. It’s about learning from each setback and having the tenacity to push forward.
In both IVF and startups, success is a mosaic crafted from persistence, adaptation, and tempered expectations. The real triumph lies not just in the outcome, but in the willingness to journey through the uncertainties, equipped with the knowledge that failure is not the opposite of success, but a part of it.
As I sit with my patients or engage with a startup team, I’m reminded that managing expectations is less about dousing hopes and more about aligning dreams with reality. It’s about fostering an environment where informed decisions lead the way. While the paths may differ, the underlying principle remains the same: understanding the landscape, preparing for the roadblocks, and having the courage to adapt.
In closing, I find that the real challenge, and indeed the real beauty, in both IVF and startups is the journey itself. It’s a journey marked by growth, learning, and the relentless pursuit of a dream. And perhaps, that is where the true essence of success lies.
As I continue to wear both my doctor’s hat and my investor’s cap, I find solace in the intersections of these worlds. Each informs the other, shaping my approach and deepening my understanding. It’s a continuous learning curve, and one that I embrace wholeheartedly, knowing that each day brings new insights, new challenges, and new reasons to remain hopeful.